GW Pharmaceuticals Plc acquisition by Jazz Pharmaceuticals Plc bodes well for Willow Biosciences Inc proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Willow Biosciences schreitet in seiner Arbeit an THC voran und plant die Einführung auf dem kanadischen Markt prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
19 gennaio 2021 13:02
Fonte: Adnkronos
#altro
VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market. We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada. There is also strong demand for a more sustainable and en